Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Gri Bio Inc (GRI)

Gri Bio Inc (GRI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,726
  • Shares Outstanding, K 3,269
  • Annual Sales, $ 0 K
  • Annual Income, $ -8,210 K
  • EBIT $ -11 M
  • EBITDA $ -9 M
  • 60-Month Beta -1.48
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 0.66
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -8.39
  • Most Recent Earnings $-1.28 on 11/14/25
  • Next Earnings Date 03/13/26
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical - Biomedical

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate -1.13
  • Number of Estimates 2
  • High Estimate -1.07
  • Low Estimate -1.18
  • Prior Year N/A
  • Growth Rate Est. (year over year) -100.11%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.5001 +5.58%
on 12/11/25
2.2900 -76.94%
on 11/24/25
-1.3420 (-71.76%)
since 11/12/25
3-Month
0.5001 +5.58%
on 12/11/25
2.2900 -76.94%
on 11/24/25
-1.2820 (-70.83%)
since 09/12/25
52-Week
0.5001 +5.58%
on 12/11/25
15.6400 -96.62%
on 01/03/25
-13.8710 (-96.33%)
since 12/12/24

Most Recent Stories

More News
GRI Bio Announces Closing of $8.0 Million Public Offering

LA JOLLA, CA, Dec. 12, 2025 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the “Company”), a biotechnology company advancing an innovative pipeline of Natural Killer T (“NKT”)...

GRI : 0.5280 (+0.21%)
GRI Bio Announces Pricing of $8,000,000 Million Public Offering

LA JOLLA, CA, Dec. 11, 2025 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the “Company”), a biotechnology company advancing an innovative pipeline of Natural Killer T (“NKT”)...

GRI : 0.5280 (+0.21%)
GRI Bio Announces Positive Topline Data from its Phase 2a Study in Idiopathic Pulmonary Fibrosis (“IPF”) 

Study met its primary endpoint demonstrating that GRI-0621 was well tolerated over 12 weeks of treatment, with no drug-related severe or serious adverse events and no increase in GI issues when used with...

GRI : 0.5280 (+0.21%)
GRI Bio Reports 6-Week Interim Lung Function Data in Ongoing Phase 2a Study in Idiopathic Pulmonary Fibrosis (“IPF”)

No decline in lung function observed at 6-week interim analysis  builds upon positive safety and biomarker data Phase 2a study fully enrolled; Topline data on track for Q3 2025 Currently available...

GRI : 0.5280 (+0.21%)
GRI Bio to Present at the H.C. Wainwright 27th Annual Global Investment Conference

Live webcast presentation with CEO, Dr. Marc Hertz, on September 9 th at 3:00 PM ET LA JOLLA, CA, Sept. 03, 2025 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the “Company”),...

GRI : 0.5280 (+0.21%)
JTC Team Companies to Present in Webull Corporate Connect Webinar Series: Biotech/MedTech on August 19-21, 2025

Register for the three-day event here

AKTX : 0.3894 (-5.02%)
NUWE : 2.28 (-6.94%)
AIM : 1.3700 (-5.52%)
AMIX : 0.7339 (-4.79%)
SNTI : 1.3100 (-7.42%)
CNSP : 7.79 (+1.78%)
NVNO : 0.3273 (-7.02%)
MBRX : 4.98 (-0.40%)
GRI : 0.5280 (+0.21%)
GRI Bio to Present at the Webull Financial Corporate Connect Webinar Series: Biotech/MedTech

Live video webcast on Wednesday, August 20 th at 2:20 PM ET LA JOLLA, CA, Aug. 14, 2025 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the “Company”), a biotechnology...

GRI : 0.5280 (+0.21%)
GRI Bio CEO, Marc Hertz, Participates in Virtual Investor “What This Means” Segment

Access the “What This Means” segment here LA JOLLA, CA, July 31, 2025 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the “Company”), a biotechnology company advancing...

GRI : 0.5280 (+0.21%)
GRI Bio Reports 6-Week Interim Biomarker Data in Ongoing Phase 2a Study in Idiopathic Pulmonary Fibrosis (“IPF”) 

Biomarkers at 6-week interim analysis show a positive impact on fibrogenesis, fibrolysis and potentially the initiation of a repair response The Independent Data Monitoring Committee (IDMC) has recommended...

GRI : 0.5280 (+0.21%)
GRI Bio Participates in the Virtual Investor “What’s Your Story” Summer Spotlight On-Demand Conference

– Video webcast now available on-demand LA JOLLA, CA, July 22, 2025 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the “Company”), a biotechnology company advancing an...

GRI : 0.5280 (+0.21%)

Business Summary

GRI Bio Inc. is a clinical stage biopharmaceutical company which focused on fundamentally changing the way inflammatory, fibrotic and autoimmune diseases are treated. GRI Bio Inc., formerly known as Vallon Pharmaceuticals Inc., is based in PHILADELPHIA, PA.

See More

Key Turning Points

3rd Resistance Point 0.6053
2nd Resistance Point 0.5827
1st Resistance Point 0.5553
Last Price 0.5280
1st Support Level 0.5053
2nd Support Level 0.4827
3rd Support Level 0.4553

See More

52-Week High 15.6400
Fibonacci 61.8% 9.8566
Fibonacci 50% 8.0701
Fibonacci 38.2% 6.2835
Last Price 0.5280
52-Week Low 0.5001

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar